(Q35680543)

9 August 2017

1 reference

title

Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment (English)

1 reference

9 August 2017

0 references

9

David Kendler

1 reference

9 August 2017

Wojciech P Olszynski

1

1 reference

9 August 2017

K Shawn Davison

2

1 reference

9 August 2017

Jonathan D Adachi

3

1 reference

9 August 2017

Jacques P Brown

4

1 reference

9 August 2017

Steven R Cummings

5

1 reference

9 August 2017

David A Hanley

6

1 reference

9 August 2017

Steven P Harris

7

1 reference

9 August 2017

Anthony B Hodsman

8

1 reference

9 August 2017

Michael R McClung

10

1 reference

9 August 2017

Paul D Miller

11

1 reference

9 August 2017

Chui Kin Yuen

12

1 reference

9 August 2017

publication date

1 January 2004

1 reference

9 August 2017

published in

Clinical Therapeutics

1 reference

9 August 2017

volume

26

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

15-28

1 reference

Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Osteoporosis in elderly men and women: effects of dietary calcium, physical activity, and body mass index

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Augmented trochanteric bone mineral density after modified physical education classes: a randomized school-based exercise intervention study in prepubescent and early pubescent children

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Physical activity and osteoporotic hip fracture risk in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Exercise and other factors in the prevention of hip fracture: the Leisure World study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Alendronate for the Treatment of Osteoporosis in Men

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Alendronate treatment of established primary osteoporosis in men: results of a 2-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

A randomized trial of nasal spray salmon calcitonin in men with idiopathic osteoporosis: effects on bone mineral density and bone markers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Prevalence of low femoral bone density in older U.S. adults from NHANES III.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

During aging, men lose less bone than women because they gain more periosteal bone, not because they resorb less endosteal bone.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Prevalence and severity of vertebral fracture: the Saunders County Bone Quality Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Symptomatic fracture incidence in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Bone density variation and its effects on risk of vertebral deformity in men and women studied in thirteen European centers: the EVOS Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Vertebral fracture definition from population-based data: preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Uncritical use of bone mineral density in absorptiometry may lead to size-related artifacts in the identification of bone mineral determinants

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Gender differences in vertebral sizes in adults: biomechanical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

The Influence of Osteoporotic Fractures on Health-Related Quality of Life in Community-Dwelling Men and Women across Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Risk factors for hip fracture in white men: the NHANES I Epidemiologic Follow-up Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Sex-specific and race-specific hip fracture rates

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

World-wide projections for hip fracture

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Mortality after all major types of osteoporotic fracture in men and women: an observational study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Survival and potential years of life lost after hip fracture in men and age-matched women

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

The components of excess mortality after hip fracture

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Survival after hip fracture: short- and long-term excess mortality according to age and gender

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Race and sex differences in mortality following fracture of the hip

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Economic implications of hip fracture: health service use, institutional care and cost in Canada.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

1 reference

7 January 2021

Pathogenesis of vertebral crush fractures in men

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Calcium accretion in girls and boys during puberty: a longitudinal analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Physiological senile involution and pathological rarefaction of bone. Quantitative and comparative histological data

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Structural trends in the aging femoral neck and proximal shaft: analysis of the Third National Health and Nutrition Examination Survey dual-energy X-ray absorptiometry data

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

The Contribution of Testosterone to Skeletal Development and Maintenance: Lessons from the Androgen Insensitivity Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Association of Hypogonadism and Estradiol Levels with Bone Mineral Density in Elderly Men from the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Preliminary evidence for impaired estrogen receptor-alpha protein expression in osteoblasts and osteocytes from men with idiopathic osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Calcaneal bone mineral density predicts fracture occurrence: a five-year follow-up study in elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Hip fracture prediction in elderly men and women: validation in the Rotterdam study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Bone density and fracture risk in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Effects of body size and skeletal site on the estimated prevalence of osteoporosis in women and men.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Noninvasive assessment of bone mineral and structure: state of the art.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Global public health and the information superhighway. Doctors and students need computer training

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Normalization of spine densitometry

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Updated data on proximal femur bone mineral levels of US adults

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Cross-sectional versus longitudinal evaluation of bone loss in men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Do men and women fracture bones at similar bone densities?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Vertebral fractures predict subsequent fractures

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Risk factors for vertebral deformities in men: relationship to number of vertebral deformities. European Vertebral Osteoporosis Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Acute and long-term increase in fracture risk after hospitalization for vertebral fracture

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

The influence of family history of hip fracture on the risk of vertebral deformity in men and women: the European Vertebral Osteoporosis Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Risk factors for proximal femur osteoporosis in men aged 50 years or older.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Total body and regional bone mineral density in men: effect of age

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Determinants of Bone Mineral Density in Older Men

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Factors associated with bone mineral density in middle-aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Risk factors for osteoporosis in men

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Case-control study of the pathogenesis and sequelae of symptomatic vertebral fractures in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Alcohol consumption and hip fractures: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Alcohol Consumption and Bone Mineral Density in Older Men

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Effect of Tobacco Consumption on Bone Mineral Density in Healthy Young Males

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

A meta-analysis of the effects of cigarette smoking on bone mineral density

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Determinants of bone mineral density in middle aged men: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Dietary calcium, sex hormones, and bone mineral density in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Validity of Self-Report of Fractures: Results from a Prospective Study in Men and Women Across Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Utility of medical and drug history in fracture risk prediction among men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Use of oral corticosteroids and risk of fractures.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Intestinal calcium absorption in men with spinal osteoporosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Alterations in calcium, vitamin D, and parathyroid hormone physiology in normal men with aging: relationship to the development of senile osteopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Influence of physical activity on vertebral deformity in men and women: results from the European Vertebral Osteoporosis Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Primary prevention of glucocorticoid-induced osteoporosis with intermittent intravenous pamidronate: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Long-term effect of testosterone therapy on bone mineral density in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Effect of testosterone treatment on bone mineral density in men over 65 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

Avoidance of vertebral fractures in men with idiopathic osteoporosis by a three year therapy with calcium and low-dose intermittent monofluorophosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990002-1

7 January 2021

10.1016/S0149-2918(04)90002-1

Identifiers

DOI

1 reference

9 August 2017

1 reference